vaxeal-emblem-small

WE DEVELOP ADVANCED IMMUNOTHERAPIES TO MEET THE GROWING NEED FOR IMPROVED ANTI-CANCER TREATMENTS.

OUR UNIQUE AND INNOVATIVE SCIENTIFIC RESEARCH, AND OUR IMPROVED UNDERSTANDING OF IMMUNILOGICAL MECHANISMS ARE AT THE HEART OF VAXEAL’S MISSION TO DELIVER CUTTING-EDGE THERAPIES. OUR VACCINES ADDRESS A WIDE SPECTRUM OF TUMORS AIMING TO IMPROVE LONG-TERM SURVIVAL WITH LIMITED ADVERSE SIDE EFFECTS.

vaxeal-highlights-img-science

SCIENCE

OUR STATE-OF-THE-ART COMBINED STRATEGIES OVERCOME THE LIMITATIONS OF TRADITIONAL VACCINE THERAPIES.

vaxeal-highlights-img-pipeline

PIPELINE

VAXEAL AGGREGATES THE EXPERTISE OF LEADING RESEARCH CENTERS PRODUCING AN EXCEPTIONAL PRODUCT PIPELINE.

vaxeal-highlights-img-team

TEAM

WE HAVE FORGED UNIQUE PARTNERSHIPS TO REDUCE THE DEVELOPMENT TIME OF OUR IMMUNOTHERAPIES.

GROWTH

VAXEAL IS TARGETING DISEASE SEGMENTS WHERE HIGH VALUE MARKETS ARE EXPERIENCING RAPID GROWTH.

PREDICTIVE ASSAYS

VAXEAL IS CONDUCTING EXTENSIVE PRE-CLINICAL STUDIES WITH HUMAN CELLS, FROM HEALTHY DONORS AND CANCER PATIENTS

INNOVATION

WE OVERCOME THE LIMITATIONS OF CURRENT CANCER VACCINE DEVELOPMENT THROUGH INNOVATIVE COMBINED THERAPIES.

We aim to improve patient access to new advanced immunotherapies as our entire product pipeline has been built according to these principles.